Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 38,912 | 27,712 | 0 | 0 |
| Operating Income | -38,912 | -27,712 | N/A | N/A |
| Other Income | 517 | 1,481 | 0 | 0 |
| Pre-tax Income | -38,395 | -26,231 | 0 | 0 |
| Net Income Continuous | -38,395 | -26,231 | N/A | N/A |
| Net Income | $-38,395 | $-26,231 | $N/A | $N/A |
| EPS Basic Total Ops | -39.50 | -34.71 | N/A | N/A |
| EPS Basic Continuous Ops | -39.50 | -34.70 | N/A | N/A |
| EPS Diluted Total Ops | -39.50 | -34.71 | N/A | N/A |
| EPS Diluted Continuous Ops | -39.50 | -34.70 | N/A | N/A |
| EBITDA(a) | $-36,429 | $-25,723 | $N/A | $N/A |